Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

HPC-A dose prediction on the optia® cell separator based on a benchmark CE2 collection efficiency: Promoting clinical efficiency, minimizing toxicity, and allowing quality control.

Cousins AF, Sinclair JE, Alcorn MJ, H A Green R, Douglas KW.

J Clin Apher. 2015 Dec;30(6):321-8. doi: 10.1002/jca.21380. Epub 2015 Jan 24.

PMID:
25619791
2.

An update on the epidemiology of contact dermatitis in commercial broilers.

Menzies FD, Goodall EA, McConaghy DA, Alcorn MJ.

Avian Pathol. 1998;27(2):174-80. doi: 10.1080/03079459808419320.

PMID:
18483983
3.

Dysregulated expression of the major telomerase components in leukaemic stem cells.

Drummond MW, Hoare SF, Monaghan A, Graham SM, Alcorn MJ, Keith WN, Holyoake TL.

Leukemia. 2005 Mar;19(3):381-9.

PMID:
15674365
4.

CML leukapheresis products can be enriched for CD34+ cells and simultaneously depleted of CD15+ cells using a simple Ab cocktail.

Richmond LJ, Alcorn MJ, Pearson C, Cameron G, Thomas T, Eaves CJ, Eaves AC, Holyoake TL.

Cytotherapy. 2002;4(5):407-13.

PMID:
12473207
5.

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro.

Graham SM, Jørgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, Holyoake TL.

Blood. 2002 Jan 1;99(1):319-25.

PMID:
11756187
6.

Adenovirus type 7 induces interleukin-8 production via activation of extracellular regulated kinase 1/2.

Alcorn MJ, Booth JL, Coggeshall KM, Metcalf JP.

J Virol. 2001 Jul;75(14):6450-9.

7.
8.

The number of CD34+ cells mobilized into the peripheral blood can predict the quality of subsequent collections.

Alcorn MJ, Farrell E, Barr J, Pearson C, Green R, Holyoake T.

J Hematother Stem Cell Res. 2000 Feb;9(1):89-93.

PMID:
10738976
9.

Selection of CD34+ cells from cryopreserved PBPC can be significantly improved by the addition of recombinant human DNase (Pulmozyme).

Alcorn MJ, Richmond LJ, Farrell E, Barr J, Pearson C, Schupp R, Franklin IM.

Cytotherapy. 1999;1(1):31-40.

PMID:
19746647
10.

Peripheral blood progenitor cell mobilisation in patients with multiple myeloma following oral idarubicin and dexamethasone (Z-Dex) induction therapy.

Cook G, Marinaki P, Farrell E, Pearson C, Alcorn MJ, Sharp RA, Tansey PJ, Franklin IM.

Leukemia. 1997 Dec;11 Suppl 5:S35-40.

PMID:
9436937
11.

CD34+ cells can be selected efficiently from cryopreserved peripheral blood progenitor cells and can retain their proliferative potential.

Alcorn MJ, Holyoake TL, Richmond LJ, Pearson C, Farrell E, Green R, Dunlop DJ, Franklin IM.

J Hematother. 1997 Oct;6(5):501-10.

PMID:
9368187
12.

CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens.

Holyoake TL, Alcorn MJ, Richmond L, Farrell E, Pearson C, Green R, Dunlop DJ, Fitzsimons E, Pragnell IB, Franklin IM.

Bone Marrow Transplant. 1997 Jun;19(11):1095-101.

13.

CD34 Selection and EX Vivo Expansion of Haemopoietic Progenitor Cells: A Review of Laboratory Methodology.

Holyoake TL, Alcorn MJ, Richmond LJ.

Hematology. 1997;2(4):261-80. doi: 10.1080/10245332.1997.11746346.

PMID:
27405230
14.

Ex vivo expansion of haemopoietic progenitor cells.

Alcorn MJ, Holyoake TL.

Blood Rev. 1996 Sep;10(3):167-76. Review.

PMID:
8932829
15.

CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity.

Alcorn MJ, Holyoake TL, Richmond L, Pearson C, Farrell E, Kyle B, Dunlop DJ, Fitzsimons E, Steward WP, Pragnell IB, Franklin IM.

J Clin Oncol. 1996 Jun;14(6):1839-47.

PMID:
8656252
16.

The CD34 antigen: potential clinical advantages of CD34 selection.

Holyoake TL, Alcorn MJ, Franklin IM.

Clin Oncol (R Coll Radiol). 1996;8(4):214-21. Review.

PMID:
8870998
17.
18.

Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue.

Dunlop DJ, Fitzsimons EJ, McMurray A, Morrison M, Kyle E, Alcorn MJ, Steward WP.

Br J Cancer. 1994 Nov;70(5):943-5.

19.

CD34+ positive haemopoietic cells: biology and clinical applications.

Holyoake TL, Alcorn MJ.

Blood Rev. 1994 Jun;8(2):113-24. Review.

PMID:
7524841
20.

Efficient isolation of human CD34 positive hemopoietic progenitor cells by immune panninga.

Holyoake TL, Alcorn MJ, Richmond LJ, Freshney MG, Pearson C, Fitzsimons E, Steward WP, Dunlop DJ, Pragnell IB.

Stem Cells. 1994 Jan;12(1):114-24. Erratum in: Stem Cells (Dayt) 1994 Mar;12(2):233.

PMID:
7511456
21.

Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.

Holyoake TL, Freshney MG, Sproul AM, Richmond LJ, Alcorn MJ, Steward WP, Fitzsimons E, Dunlop DJ, Franklin IM, Pragnell IB.

Stem Cells. 1993 Oct;11 Suppl 3:122-8.

PMID:
8298472
23.

Economic effects of clinical chicken anemia agent infection on profitable broiler production.

McIlroy SG, McNulty MS, Bruce DW, Smyth JA, Goodall EA, Alcorn MJ.

Avian Dis. 1992 Jul-Sep;36(3):566-74.

PMID:
1417588
24.

Autologous bone marrow transplantation in acute lymphoblastic leukemia--preclinical immunologic studies.

Janossy G, Campana D, Burnett A, Coustan-Smith E, Timms A, Bekassy AN, Hann I, Alcorn MJ, Totterman T, Simonsson B, et al.

Leukemia. 1988 Aug;2(8):485-95.

PMID:
3045431
25.

Haematological reconstitution following high dose and supralethal chemo-radiotherapy using stored, non-cryopreserved autologous bone marrow.

Burnett AK, Tansey P, Hills C, Alcorn MJ, Sheehan T, McDonald GA, Banham SW.

Br J Haematol. 1983 Jun;54(2):309-16.

PMID:
6303383
26.

Fatal disseminated BCG infection in an 18-year-old boy.

Mackay A, Macleod T, Alcorn MJ, Laidlaw M, Macleod IM, Millar JS, Stack BH, White RG.

Lancet. 1980 Dec 20-27;2(8208-8209):1332-4.

PMID:
6109152
27.

Wiskott-Aldrich syndrome with partial response to transfer factor.

Mackie RM, Alcorn MJ, Stevenson RD, Cochran T, McSween RN.

Br J Dermatol. 1978 May;98(5):567-71.

PMID:
656329

Supplemental Content

Loading ...
Support Center